Compare Exelixis Inc. Common Stock (EXEL) vs Globalstar (GSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Globalstar — how do they compare? Exelixis Inc. Common Stock trades at $60.31 (market cap $14.62B), while Globalstar trades at $83.63 (market cap $10.78B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Globalstar is more actively traded (723,953 versus 2,684,957). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Globalstar for 20 Days on average.
| EXEL | GSAT | |
|---|---|---|
Market Cap | $14.62B | $10.78B |
Volume | 2,684,957 | 723,953 |
Sector | Health | Media |
52-Week High | $59.13 | $84.43 |
52-Week Low | $34.54 | $41.54 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $13.95B | $10.79B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →
